Browse studies

Find your next paid study

27,375 recruiting studies available now

A Novel Intervention to Improve Care for Older Sexual and Gender Minority (SGM) Adults With Serious Illness and Especially Those With Alzheimer's Disease and Related Dementias (ADRD)

Older sexual and gender minority (SGM) patients are at risk for receiving inequitable end-of-life care; those with Alzheimer's disease and related dementias (A…

Sexual and Gender MinoritiesHospiceAlzheimer's Disease and Related Dementias

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT05877391

Observational

A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standar…

Mohs Micrographic SurgeryCutaneous MalignancyMohs Surgical Defect

Estimated

~$10 – $1,125

Actual pay is set by the research site.

BioLab HoldingsNCT07695389

Phase 1

Phase 1/2 First-in-Human Study to Evaluate the Safety, Tolerability, and Efficacy of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome

The goal of this clinical trial is to learn if MZ-1866 is a safe and tolerable treatment for children and adults with Pitt Hopkins Syndrome. To evaluate the s…

Pitt Hopkins Syndrome

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Mahzi TherapeuticsNCT07135050

Phase 3

A Phase 3b/4, Multicenter, Parallel-Group, Double-Blind, Placebo Controlled, Two-Arm, Long-Term Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium on Clinical Outcomes in Participants With Primary Biliary Cholangitis (PBC)

Long-Term Study to Evaluate the Safety and Efficacy in Participants with Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes (EPICS-V)

Primary Biliary Cholangitis

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Zydus Therapeutics Inc.NCT07216235

Phase 4

Effect of Albumin Versus Routine Care on Hemodynamic Response and Stability in Patients With Preeclampsia Guided by a Non-invasive Hemodynamic Monitoring System During Cesarean Delivery With Spinal Anesthesia - A Randomized Controlled Study

The purpose of this study is to compare the effect of albumin versus routine care on hemodynamic response and stability in pre-eclamptic patients during cesare…

Pre-Eclampsia

Estimated

~$25 – $1,000

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT06107335

Observational

Influence of Acute Mental Fatigue on Muscle Strength and Limb Symmetry in Healthy Adults

This study will investigate the acute effects of mental fatigue on lower-extremity muscle strength and limb symmetry in healthy young adults. Participants will…

Mental FatigueMuscle Strength Dynamometer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Florida Institute for Human and Machine CognitionNCT07846618

Observational

The Carevix Device: Assessing Pain and Effectiveness of a Suction-based Cervical Stabilizer for IUD Insertions in the Clinic Setting: a Randomized, Controlled Trial (CARE)

The goal of this clinical trial is to evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between …

IUDAbnormal Uterine BleedingPain, Cervical

Estimated

~$10 – $750

Actual pay is set by the research site.

Indiana UniversityNCT07290517

Phase 1

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

This is an open label, non-randomized, phase 1 study of anti-CD19 CAR-T cells against relapsed CD19 positive NHL, CLL and ALL based in a lymphodepletion regime…

Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of UtahNCT06227026

Phase 1

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CT

This phase I trial studies how well fluorine F 18 fluorthanatrace positron emission tomography (PET)/computed tomography (CT) works in patients with solid tumo…

Breast CarcinomaFallopian Tube CarcinomaOvarian Carcinoma+5 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT03604315

Phase 2

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Anti-CD14 Treatment With a Recombinant Chimeric Monoclonal Antibody (IC14) in Hospitalized Patients With Acute Respiratory Distress Syndrome

Hospitalized patients with ARDS will be randomized to intravenous treatment with a monoclonal antibody against CD14, called IC14, or placebo. They will be foll…

Acute Respiratory Distress SyndromeAdult Respiratory Distress SyndromeAcute Lung Injury+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Implicit BioscienceNCT06513949

Phase 2

Human Penile Allotransplantation

Injuries to the genitalia are of concern to the military with emphasis placed on the surgical reconstruction and psychological health of these Wounded Warriors…

AmputationWounds and InjuriesAmputation, Traumatic+6 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Johns Hopkins UniversityNCT02395497

Phase 3

A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia

The main objective of the study is to evaluate NBI-1117568 compared with placebo in delaying relapse of symptoms of schizophrenia in adults who have a stable r…

Schizophrenia

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Neurocrine BiosciencesNCT07227818